Day: May 14, 2025

COMPANY ANNOUNCEMENT NO. 8-2025 FLSmidth & Co. A/S 14 May 2025 Copenhagen, DenmarkToday, the Board of Directors of FLSmidth have approved the Q1 2025 Interim Financial Report. Highlights in Q1 2025:14% increase in Mining Service revenue driven by effective backlog management and order execution Mining Adjusted EBITA margin of 15.1% reflecting continued profitability improvements Negative growth in Cement order intake and revenue continue to reflect de-risking and impact from divestments Cement Adjusted EBITA margin of 9.5% reflecting good strategic execution, with reduced SG&A costs and effective de-risking FLSmidth has entered exclusive negotiations for the potential divestment of the Cement business The financial guidance for the full year 2025 was raised on 14 May 2025 (ref. Company Announcement no. 7-2025) Continued progression...

 FY 2024/25 results:Book-to-bill ratio at 1.1 and organic sales up 6.6%1 aEBIT2 of €1,177 million, up 18%, i.e. margin of 6.4% aNet profit2 at €498 million Free Cash Flow2 at €502 millionFY 2025/26 outlookGroup and Rolling stock book-to-bill ratio above 1 Sales organic growth between 3% to 5% aEBIT margin around 7% Free Cash Flow within a €200 to €400 million range Pronounced seasonality driving Free cash-flow consumption of up to €(1.0) billion in H1Confirmed 3-year cumulative Free-cash-flow of at least €1.5 billion FY24/25 to FY26/27 Medium-term ambitions confirmed 14 May 2025 – Between 1 April 2024 and 31 March 2025, Alstom booked €19.8 billion of orders. Sales were €18.5 billion, resulting in a book-to-bill ratio at 1.1. The backlog reached €95 billion, providing strong visibility on future sales. Gross...

Press ReleaseNicox Announces Results of the Exploratory Whistler Phase 3b Glaucoma Trial Several aqueous humor parameters stimulated by nitric oxide were statistically significant or trended in favor of NCX 470; likewise those that respond to prostaglandin analogs Episcleral venous pressure changes did not show a trend vs. placebo Safety profile is consistent with that of the first Phase 3 trial, Mont Blanc NCX 470 intraocular pressure lowering efficacy and safety have already been demonstrated in the Phase 3 glaucoma trial, Mont Blanc Timeline and planning for New Drug Application submissions remain on trackMay 14, 2025 – release at 7:30 am CET Sophia Antipolis, France Nicox SA (Euronext Growth Paris: FR0013018124, ALCOX), an international ophthalmology company, today announced the results of the Whistler Phase 3b exploratory...

Highlights first quarter 2025Solid start of the year with group turnover at 993 million euros, up 10% compared to 900 million euros a year ago Orderbook remains at a healthy level at 7.6 billion euros, compared to 7.5 billion euros a year ago, excluding orderbook Havfram Management reaffirms guidance for the year for turnover and EBITDA margin at least in line with last year Subsequent to quarter end, DEME has acquired Havfram, a Norwegian offshore wind contractor, supporting DEME’s ambition to expand its footprint in the offshore wind energy market and bolster its competitive edge in turbine and foundation installations.AttachmentP2025 DEME Trading update Q1 2025 ENG

Trondheim, 14 May 2025: In the first quarter, NORBIT recorded revenues of NOK 521.7 million, an increase of 29 per cent from the corresponding quarter of 2024. The EBIT result was NOK 127.4 million, representing a margin of 24 per cent. Diluted earnings per share were NOK 1.40 for the first quarter, up from NOK 0.50 one year earlier.The Oceans segment delivered its second highest revenues ever of NOK 232.7 million, an increase of 92 per cent from the same quarter in 2024, with an EBIT margin of 35 per cent. The Connectivity segment reported NOK 145.9 million in revenues, largely in line with Q1 2024, and an EBIT margin of 28 per cent. The Product Innovation & Realization (PIR) segment saw revenue growth of 11 per cent, to NOK 160.6 million, with an EBIT margin of 14 per cent.“Through years of market-driven innovation and...

Marimekko Corporation, Interim Report, 14 May 2025 at 8.00 a.m. EEST INTERIM REPORT OF MARIMEKKO CORPORATION, 1 January–31 March 2025: Marimekko’s net sales in the first quarter grew and operating profit was at a good level This release is a summary of Marimekko’s interim report for the January–March period of 2025. The complete report is attached to this release as a pdf file and it is also available on the company’s website at company.marimekko.com under Releases & publications. The first quarter in briefMarimekko’s net sales increased by 5 percent and totaled EUR 39.6 million (37.7). Net sales were boosted in particular by the growth of wholesale sales in Europe and increased retail sales in Finland. Net sales development was negatively impacted by timing-related factors: in the comparable year, a large amount of non-recurring...

ABN AMRO Bank posts net profit of EUR 619 million in Q1 2025 14 May 2025 Key messagesSolid results: Net profit of EUR 619 million, with a return on equity of around 10% Good business momentum: Mortgage portfolio grew by EUR 1.7 billion and corporate loans by EUR 0.9 billion Resilient net interest income despite impact from lower short-term interest rates Continued fee growth: Increase of 8% compared to Q1 2024, with contributions from all client units Cost discipline: Underlying costs declined 5% compared to Q4 2024; guidance for full-year 2025 unchanged Solid credit quality: Impairments of EUR 5 million, reflecting net additions for individual files offset by model-related releases Strong capital position: Basel IV CET1 ratio of 14.7% Capital Markets Day to be held in NovemberMarguerite Bérard, CEO:“As we reflect on the first quarter...